"Inspirom"--overview of the relationship between the pulmonologist and the COPD patient in Romania.

The aim of the study was to provide an insight of the investigation related to multiple clinical and care problems encountered by COPD patients in relations with the practitioner. In a 6 month prospective observational study (sponsored by Servier Pharmaceutical Company), started in 2012 and completed in 2013, in out-patient settings, we involved 39 doctors (from different pneumology centers of the country) and assessed the involvement of both doctors and 1,131 patients in their observance of the therapeutic indications, as well as patients' compliance with the medical instructions, 2 months after the therapeutic indication. In this observational study we analyzed through the new GOLD classification the COPD patients at the time of recruitment until the next monitoring visit in two months. We applied for the first time this new GOLD classification for Romanian COPD patients as an overview in a period of follow-up. Results showed that at detection time, 56% patients had mild and moderate obstruction (stage 1-2 GOLD) and 44% patients are in old GOLD stage 3-4. When we used new GOLD classification, 46.4% patients are in GOLD C and D stages, with 35% having CAT over 20 and 25% an mMRC over 2. There findings can be alarm signals related to the large number of smokers, the lack of involvement of doctors in fighting tobacco consumption, and over-assessment of mild stages of the disease. All these elements can guide future prevention programs and actions of active screening for this disease.